VECTORS INCLUDING FOREIGN GENES AND NEGATIVE SELECTIVE MARKERS Read more about VECTORS INCLUDING FOREIGN GENES AND NEGATIVE SELECTIVE MARKERS Patent Cooperation TreatyPCT/US1992/009130Filed on 1992-10-28
BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS Read more about BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS Patent Cooperation TreatyPCT/US92/009127Filed on 1992-10-30
METHOD TO INDUCE CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR A BROAD ARRAY OF HIV-1 ISOLATES USING HYBRID SYNTHETIC PEPTIDES Read more about METHOD TO INDUCE CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR A BROAD ARRAY OF HIV-1 ISOLATES USING HYBRID SYNTHETIC PEPTIDES Patent Cooperation TreatyPCT/US1992/007714Filed on 1992-09-18
METHOD OF DETECTING INFECTIOUS VIRUS STRAINS Read more about METHOD OF DETECTING INFECTIOUS VIRUS STRAINS Patent Cooperation TreatyPCT/US1992/007386Filed on 1992-09-08
ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF Read more about ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF Patent Cooperation TreatyPCT/US1992/007142Filed on 1992-08-26
EUKARYOTIC EXPRESSION VECTORS WITH REGULATION OF RNA PROCESSING Read more about EUKARYOTIC EXPRESSION VECTORS WITH REGULATION OF RNA PROCESSING Patent Cooperation TreatyPCT/US1992/004011Filed on 1992-05-21
Recombinant Virus Expressing Carcinoembryonic Antigen and Methods of Use Thereof Read more about Recombinant Virus Expressing Carcinoembryonic Antigen and Methods of Use Thereof Patent Cooperation TreatyPCT/US1992/003843Filed on 1992-05-06
MONOCLONAL ANTIBODIES FOR SPECIFIC HUMAN THYMIDYLATE SYNTHASE Read more about MONOCLONAL ANTIBODIES FOR SPECIFIC HUMAN THYMIDYLATE SYNTHASE Patent Cooperation TreatyPCT/US1992/003114Filed on 1992-04-24
AN ANTI-HIV PROTEIN, TAP 29, FROM TRICHOSANTHES, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF Read more about AN ANTI-HIV PROTEIN, TAP 29, FROM TRICHOSANTHES, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF Patent Cooperation TreatyPCT/US1992/003089Filed on 1992-04-15
ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma Read more about ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma Patent Cooperation TreatyPCT/US03/16298Filed on 2003-05-20